LaBrosse Nicole sold HALO
February 23, 2026 · Form 4 insider transaction
LaBrosse Nicole sold 3,608 shares of Halozyme Therapeutics, Inc. at $70.64 per share, a transaction worth $254.9K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
3,608
Price
$70.64
Total value
$254.9K
InsiderLaBrosse Nicole
RoleOfficer
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateFebruary 23, 2026
Filing dateFebruary 24, 2026
Shares owned after38,494
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reported disposition of 3,608 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.